episode 66

Disrupting Drug Discovery and Development With AI

Data Science Leaders | 38:12 | February 15, 2024

Get new episodes 
in your inbox

Return to podcast home

There is no such thing as an AI drug, but AI and ML-models are driving the next wave of new treatments. In this episode, Brandon Allgood, Chief Data Officer at FogPharma and serial entrepreneur at the intersection of ML and Biopharma, shares his insights on how AI is disrupting the traditional process of drug discovery and development.

Join us as we discuss:

  • Why AI is so powerful for drug discovery
  • What data science needs to learn from engineering
  • How drug discovery processes need to be rebuilt with AI models at their core

Popular episodes

Featured Guest

Mike Gualtieri, VP and Principal Analyst at Forrester

EPISODE 72May 03, 2024

Surviving and thriving as an AI leader in a Gen AI world

Listen Now | 43:41

James Cham

Partner, Bloomberg Beta

EPISODE 71April 11, 2024

Unlocking the disruptive potential of generative AI: a VC perspective

Listen Now | 28:49

Volodimir Olexiouk

Director of Scientific Engagement and Data Science Team Lead, BioLizard

EPISODE 70March 28, 2024

Overcoming the data challenges of AI-driven drug discovery

Listen Now | 36:49

See why Fortune 100 data science leaders choose Domino